776
Views
0
CrossRef citations to date
0
Altmetric
Review

VATE: VAlidation of high TEchnology based on large database analysis by learning machine

, , , , , , , , , & show all
Pages 435-450 | Published online: 19 Nov 2014

References

  • Lambin P , van StiphoutRGPM, StarmansMHWet al. Predicting outcomes in radiation oncology – multifactorial decision support systems. Nat. Rev. Clin. Oncol.10(1), 27–40 (2013).
  • Lambin P , Rios-VelazquezE, LeijenaarRet al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur. J. Cancer48(4), 441–446 (2012).
  • Yamane LS , Scapulatempo-NetoC, AlvarengaLet al. KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy. Oncol. Rep. doi:10.3892/or.2014.3338 (2014) ( Epub ahead of print).
  • Lin C-C , LinJ-K, LinT-Cet al. The prognostic role of microsatellite instability, codon-specific KRAS, and BRAF mutations in colon cancer. J. Surg. Oncol. doi:10.1002/jso.23675 (2014) ( Epub ahead of print).
  • Bentzen SM . Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat. Rev. Cancer6(9), 702–713 (2006).
  • Fowler JF . 21 years of biologically effective dose. Br. J. Radiol.83(991), 554–568 (2010).
  • Glynne-Jones R , HadakiM, HarrisonM. The status of targeted agents in the setting of neoadjuvant radiation therapy in locally advanced rectal cancers. J. Gastrointest. Oncol.4(3), 264–284 (2013).
  • Bonner JA , HarariPM, GiraltJet al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol.11(1), 21–2 (2010).
  • NCI . NCI Dictionary of terms: personalized medicine. www.cancer.gov/dictionary?cdrid=561717
  • Booth CM , TannockIF. Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence. Br. J. Cancer110(3), 551–555 (2014).
  • Zietman AL . Falsification, fabrication, and plagiarism: the unholy trinity of scientific writing. Int. J. Radiat. Oncol. Biol. Phys.87(2), 225–227 (2013).
  • Tyldesley S , Zhang-SalomonsJ, GroomePAet al. Association between age and the utilization of radiotherapy in Ontario. Int. J. Radiat. Oncol. Biol. Phys.47(2), 469–480 (2000).
  • Faivre J , LemmensVE, QuipourtV, BouvierAM. Management and survival of colorectal cancer in the elderly in population-based studies. Eur. J. Cancer43(15), 2279–2284 (2007).
  • Bach PB , CramerLD, WarrenJL, BeggCB. Racial differences in the treatment of early-stage lung cancer. N. Engl. J. Med.341(16), 1198–1205 (1999).
  • Boyd C , Zhang-SalomonsJY, GroomePA, MackillopWJ. Associations between community income and cancer survival in Ontario, Canada, and the United States. J. Clin. Oncol.17(7), 2244–2255 (1999).
  • Hershman D , McBrideR, JacobsonJSet al. Racial disparities in treatment and survival among women with early-stage breast cancer. J. Clin. Oncol.23(27), 6639–6646 (2005).
  • Pearcey R , MiaoQ, KongW, Zhang-SalomonsJ, MackillopWJ. Impact of adoption of chemoradiotherapy on the outcome of cervical cancer in Ontario: results of a population-based cohort study. J. Clin. Oncol.25(17), 2383–8 (2007).
  • Booth CM . Evaluating patient-centered outcomes in the randomized controlled trial and beyond: informing the future with lessons from the past. Clin. Cancer Res.16(24), 5963–5971 (2010).
  • Sanoff HK , CarpenterWR, StürmerTet al. Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. J. Clin. Oncol.30(21), 2624–2634 (2012).
  • Cheung WY , ShiQ, O'ConnellMet al. The predictive and prognostic value of sex in early-stage colon cancer: a pooled analysis of 33,345 patients from the ACCENT database. Clin. Colorectal Cancer12(3), 179–187 (2013).
  • Lieu CH , RenfroLA, de GramontAet al. Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials Program. J. Clin. Oncol. doi:10.1200/JCO.2013.54.9329 (2014) ( Epub ahead of print).
  • Valentini V , van StiphoutRGPM, LammeringGet al. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J. Clin. Oncol.29(23), 3163–3172 (2011).
  • Valentini V , AristeiC, GlimeliusBet al. Multidisciplinary rectal cancer management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). Radiother. Oncol.92(2), 148–163 (2009).
  • Haustermans K , DebucquoyA, LambrechtM. The ESTRO Breur Lecture 2010: toward a tailored patient approach in rectal cancer. Radiother. Oncol.100(1), 15–21 (2011).
  • Van den Bogaard J , JanssenMHM, JanssensGet al. Residual metabolic tumor activity after chemo-radiotherapy is mainly located in initially high FDG uptake areas in rectal cancer. Radiother. Oncol.99(2), 137–141 (2011).
  • Lambin P , RoelofsE, ReymenBet al. “Rapid Learning health care in oncology” – an approach towards decision support systems enabling customised radiotherapy’. Radiother. Oncol.109(1), 159–164 (2013).
  • Vickers AJ . Prediction models: revolutionary in principle, but do they do more good than harm?J. Clin. Oncol.29(22), 2951–2952 (2011).
  • (AJCC) AJC on C . AJCC 7th Edition - Colon and Rectum Cancer Staging (2007). https://cancerstaging.org/references-tools/quickreferences/Pages/default.aspx
  • Sobin L , ParkinDM. International Classifi cation of Diseases for Oncology. Third Edition. World Health Organization, Geneva, Switzerland. http://whqlibdoc.who.int/publications/2000/9241545348_eng.pdf
  • CTEP . Common Terminology Criteria for Adverse Events v3.0 (CTCAE) (2006). http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf
  • Services H . Common Terminology Criteria for Adverse Events (CTCAE) (2010). http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010–06–14_QuickReference_5x7.pdf
  • Kumar V , GuY, BasuSet al. Radiomics: the process and the challenges. Magn. Reson. Imaging30(9), 1234–1248 (2012).
  • Valentini V , SchmollHJ, Velde CJ VanDe. Multidisciplinary Management of Rectal Cancer.Springer-Verlag Berlin, Heidelberg, Germany (2012).
  • Lewalle P , RodriguesJM, ZanstraPet al. A deployment and Research Roadmap for Semantic Interoperability: the EU semantic health project. Stud. Health Technol. Inform.136, 635–640 (2008).
  • Roelofs E , DekkerA, MeldolesiE, van StiphoutRGPM, ValentiniV, LambinP. International data-sharing for radiotherapy research: an open-source based infrastructure for multicentric clinical data mining. Radiother. Oncol.110(2), 370–374 (2014).
  • Maastricht Radiation Oncology. Validation of a predictive model after complete response in rectal cancer (Thunder). ClinicalTrials.gov Identifier:NCT00969657. www.clinicaltrials.gov/show/NCT00969657
  • Jayasurya K , FungG, YuSet al. Comparison of Bayesian network and support vector machine models for two-year survival prediction in lung cancer patients treated with radiotherapy. Med. Phys.37(4), 1401–1407 (2010).
  • Dehing-Oberije C , YuS, De RuysscherDet al. Development and external validation of prognostic model for 2-year survival of non-small-cell lung cancer patients treated with chemoradiotherapy. Int. J. Radiat. Oncol. Biol. Phys.74(2), 355–62 (2009).
  • MAASTRO Clinic . MAASTRO prediction website. www.predictcancer.org
  • Recommendation WWWC . Resource Description Framework (RDF) Model and Syntax Specification (1999). www.w3.org/TR/1999/REC-rdf-syntax-19990222
  • Assélé Kama A , ChoquetR, MelsG, DanielC, CharletJ, JaulentM-C. An ontological approach for the exploitation of clinical data. Stud. Health Technol. Inform.192, 142–146 (2013).
  • Meldolesi E , van SoestJ, DinapoliNet al. An umbrella protocol for standardized data collection (SDC) in rectal cancer: a prospective uniform naming and procedure convention to support personalized medicine. Radiother. Oncol.112(1), 59–62 (2014).
  • Semantic Web platform. http://tinyurl.com/VateSPARQL1
  • National Cancer Institute: Comprehensive Cancer Information at the National Institute of Health. www.ncicb.nci.nih.gov
  • Luta G , FordMB, BondyM, ShieldsPG, StameyJD. Bayesian sensitivity analysis methods to evaluate bias due to misclassification and missing data using informative priors and external validation data. Cancer Epidemiol.37(2), 121–126 (2013).
  • Marsolo K . Approaches to facilitate institutional review board approval of multicenter research studies. Med. Care50(Suppl. 7), S77–S81 (2012).
  • Boyd S . Distributed optimization and statistical learning via the alternating direction method of multipliers. Found. Trends Mach. Learn.3(1), 1–122 (2010).
  • Harrel F . Resampling, Validating, Describing, and Simplifying the Model.Springer-Verlag, NY, USA, 87–103 (2001).
  • Oh JH , CraftJ, Al LoziRet al. A Bayesian network approach for modeling local failure in lung cancer. Phys. Med. Biol.56(6), 1635–1651 (2011).
  • Van Stiphout RGPM , LammeringG, BuijsenJet al. Development and external validation of a predictive model for pathological complete response of rectal cancer patients including sequential PET-CT imaging. Radiother. Oncol.98(1), 126–133 (2011).
  • Vickers AJ , CroninAM, ElkinEB, GonenM. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med. Inform. Decis. Mak.8, 53 (2008).
  • Vickers AJ , ElkinEB. Decision curve analysis: a novel method for evaluating prediction models. Med. Decis. Making26(6), 565–574 (2006).
  • Wu Y , JiangX, KimJ, Ohno-MachadoL. Grid Binary LOgistic REgression (GLORE): building shared models without sharing data. J. Am. Med. Inform. Assoc.19(5), 758–764 (2012).
  • Liu K , KarguptaH, MemberS, RyanJ. Random projection-based multiplicative data perturbation for privacy preserving distributed data mining. IEEE Trans. Knowl. Data Eng.18(1), 92–106 (2006).
  • Valentini V , LambinP, MyersonRJ. Is it time for tailored treatment of rectal cancer? From prescribing by consensus to prescribing by numbers. Radiother. Oncol.102(1), 1–3 (2012).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.